TRAF3IP2 and thyroid cancer: To further confirm the regulation of KDM1A on the stemness properties of thyroid cancer, we used two independent shRNAs to suppress the expression of KDM1A in two ATC cell lines with relatively high endogenous KDM1A expression (CAL-62 and ACT1) (Figure 2A).